AU690791B2 - Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity - Google Patents

Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Info

Publication number
AU690791B2
AU690791B2 AU42603/96A AU4260396A AU690791B2 AU 690791 B2 AU690791 B2 AU 690791B2 AU 42603/96 A AU42603/96 A AU 42603/96A AU 4260396 A AU4260396 A AU 4260396A AU 690791 B2 AU690791 B2 AU 690791B2
Authority
AU
Australia
Prior art keywords
erythromycin
ethyl
oxime
formula
hexylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42603/96A
Other languages
English (en)
Other versions
AU4260396A (en
Inventor
Enrico Albini
Daniela Botta
Franco Pellacini
Stefano Romagnano
Francesco Santangelo
Giovanna Schioppacassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon Group SpA
Original Assignee
Zambon Group SpA
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA, Zambon SpA filed Critical Zambon Group SpA
Publication of AU4260396A publication Critical patent/AU4260396A/en
Application granted granted Critical
Publication of AU690791B2 publication Critical patent/AU690791B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU42603/96A 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity Ceased AU690791B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
ITMI94A2496 1994-12-13
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (2)

Publication Number Publication Date
AU4260396A AU4260396A (en) 1996-07-03
AU690791B2 true AU690791B2 (en) 1998-04-30

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42603/96A Ceased AU690791B2 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Country Status (35)

Country Link
US (1) US5847092A (zh)
EP (1) EP0797579B1 (zh)
JP (1) JPH10510520A (zh)
KR (1) KR100367559B1 (zh)
CN (1) CN1046535C (zh)
AP (1) AP739A (zh)
AT (1) ATE190620T1 (zh)
AU (1) AU690791B2 (zh)
BG (1) BG63261B1 (zh)
BR (1) BR9510015A (zh)
CA (1) CA2207029A1 (zh)
CZ (1) CZ289943B6 (zh)
DE (1) DE69515694T2 (zh)
DK (1) DK0797579T3 (zh)
EE (1) EE03401B1 (zh)
ES (1) ES2144154T3 (zh)
FI (1) FI972493A0 (zh)
GE (1) GEP20012391B (zh)
GR (1) GR3033622T3 (zh)
HU (1) HU220631B1 (zh)
IT (1) IT1276901B1 (zh)
LT (1) LT4276B (zh)
LV (1) LV11898B (zh)
MD (1) MD1788G2 (zh)
NO (1) NO309816B1 (zh)
NZ (1) NZ297446A (zh)
OA (1) OA10491A (zh)
PL (1) PL182053B1 (zh)
PT (1) PT797579E (zh)
RO (1) RO116282B1 (zh)
RU (1) RU2152951C1 (zh)
SI (1) SI9520124A (zh)
TJ (1) TJ306B (zh)
UA (1) UA48958C2 (zh)
WO (1) WO1996018633A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349545A (en) * 1980-01-11 1982-09-14 Roussel Uclaf Novel erythromycin a derivatives
US5444051A (en) * 1990-11-21 1995-08-22 Roussel Uclaf Erythromycin compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
PT86800B (pt) 1987-02-24 1992-05-29 Beecham Group Plc Processo para a preparacao de derivados de eritromicina
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349545A (en) * 1980-01-11 1982-09-14 Roussel Uclaf Novel erythromycin a derivatives
US5444051A (en) * 1990-11-21 1995-08-22 Roussel Uclaf Erythromycin compounds

Also Published As

Publication number Publication date
OA10491A (en) 2002-04-10
DK0797579T3 (da) 2000-06-05
DE69515694T2 (de) 2000-10-26
ATE190620T1 (de) 2000-04-15
SI9520124A (sl) 1998-04-30
FI972493A (fi) 1997-06-12
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
IT1276901B1 (it) 1997-11-03
EE03401B1 (et) 2001-04-16
HU220631B1 (hu) 2002-03-28
AU4260396A (en) 1996-07-03
NO309816B1 (no) 2001-04-02
RO116282B1 (ro) 2000-12-29
JPH10510520A (ja) 1998-10-13
DE69515694D1 (de) 2000-04-20
CN1169727A (zh) 1998-01-07
UA48958C2 (uk) 2002-09-16
GEP20012391B (en) 2001-03-25
CZ178697A3 (en) 1997-12-17
PL320688A1 (en) 1997-10-27
NO972702D0 (no) 1997-06-12
GR3033622T3 (en) 2000-10-31
CN1046535C (zh) 1999-11-17
AP739A (en) 1999-03-24
LV11898B (en) 1998-03-20
US5847092A (en) 1998-12-08
ES2144154T3 (es) 2000-06-01
PL182053B1 (pl) 2001-10-31
LT97116A (en) 1997-10-27
RU2152951C1 (ru) 2000-07-20
PT797579E (pt) 2000-08-31
KR100367559B1 (ko) 2003-04-21
MD970243A (en) 1999-05-31
EP0797579B1 (en) 2000-03-15
WO1996018633A1 (en) 1996-06-20
HUT77126A (hu) 1998-03-02
EP0797579A1 (en) 1997-10-01
TJ306B (en) 2001-08-06
BG63261B1 (bg) 2001-07-31
CA2207029A1 (en) 1996-06-20
BG101570A (en) 1998-02-27
EE9700124A (et) 1997-12-15
LV11898A (lv) 1997-12-20
AP9700989A0 (en) 1997-07-31
BR9510015A (pt) 1997-10-28
CZ289943B6 (cs) 2002-04-17
NZ297446A (en) 1999-06-29
FI972493A0 (fi) 1997-06-12
ITMI942496A0 (it) 1994-12-13
NO972702L (no) 1997-08-13
MX9704253A (es) 1997-09-30
LT4276B (lt) 1998-01-26
ITMI942496A1 (it) 1996-06-13

Similar Documents

Publication Publication Date Title
EP1529053B1 (en) Macrolide compounds endowed with antiinflammatory activity
KR100486053B1 (ko) 신규에리트로마이신유도체,그의제조방법및약제로서의그의용도
AU690791B2 (en) Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
FR2473525A1 (fr) Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
HU193886B (en) Process for preparing epimer azahomoerythromycin a derivatives
IL167882A (en) 9a-AZALIDES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
US4579940A (en) 14-de(hydroxymethyl)-mycaminosyltylonolide derivatives
MXPA97004253A (en) Derivatives of 9-0-oxima of erythromycin or dotated with antibioot activity
DE602004010110T2 (de) Neue 14- und 15-gliedrige ringverbindungen
EP1100806B1 (en) Erythromycin derivative with antibiotic activity
KR20050085555A (ko) 아잘라이드 계열의 신규한 반합성 마크로라이드 항생제
USRE38520E1 (en) Erythromycin derivatives, method for preparing same, and use thereof as drugs